| Product Code: ETC11226991 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Type 1 Diabetes Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Type 1 Diabetes Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Type 1 Diabetes Market - Industry Life Cycle |
3.4 Israel Type 1 Diabetes Market - Porter's Five Forces |
3.5 Israel Type 1 Diabetes Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Type 1 Diabetes Market Revenues & Volume Share, By Treatment Approach, 2021 & 2031F |
3.7 Israel Type 1 Diabetes Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Israel Type 1 Diabetes Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Israel Type 1 Diabetes Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of type 1 diabetes in Israel |
4.2.2 Technological advancements in diabetes management and treatment |
4.2.3 Growing awareness and focus on diabetes care and prevention |
4.3 Market Restraints |
4.3.1 High cost of diabetes management and treatment |
4.3.2 Limited access to specialized healthcare services in certain regions of Israel |
5 Israel Type 1 Diabetes Market Trends |
6 Israel Type 1 Diabetes Market, By Types |
6.1 Israel Type 1 Diabetes Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Type 1 Diabetes Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Israel Type 1 Diabetes Market Revenues & Volume, By Insulin Therapy, 2021 - 2031F |
6.1.4 Israel Type 1 Diabetes Market Revenues & Volume, By Blood Glucose Monitoring, 2021 - 2031F |
6.1.5 Israel Type 1 Diabetes Market Revenues & Volume, By Artificial Pancreas, 2021 - 2031F |
6.1.6 Israel Type 1 Diabetes Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.2 Israel Type 1 Diabetes Market, By Treatment Approach |
6.2.1 Overview and Analysis |
6.2.2 Israel Type 1 Diabetes Market Revenues & Volume, By Rapid-Acting, 2021 - 2031F |
6.2.3 Israel Type 1 Diabetes Market Revenues & Volume, By Continuous Monitoring, 2021 - 2031F |
6.2.4 Israel Type 1 Diabetes Market Revenues & Volume, By Closed-Loop System, 2021 - 2031F |
6.2.5 Israel Type 1 Diabetes Market Revenues & Volume, By Beta Cell Regeneration, 2021 - 2031F |
6.3 Israel Type 1 Diabetes Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Israel Type 1 Diabetes Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Israel Type 1 Diabetes Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 Israel Type 1 Diabetes Market Revenues & Volume, By Home Care, 2021 - 2031F |
6.3.5 Israel Type 1 Diabetes Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
6.4 Israel Type 1 Diabetes Market, By End Use |
6.4.1 Overview and Analysis |
6.4.2 Israel Type 1 Diabetes Market Revenues & Volume, By Patients, 2021 - 2031F |
6.4.3 Israel Type 1 Diabetes Market Revenues & Volume, By Healthcare Professionals, 2021 - 2031F |
6.4.4 Israel Type 1 Diabetes Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.5 Israel Type 1 Diabetes Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
7 Israel Type 1 Diabetes Market Import-Export Trade Statistics |
7.1 Israel Type 1 Diabetes Market Export to Major Countries |
7.2 Israel Type 1 Diabetes Market Imports from Major Countries |
8 Israel Type 1 Diabetes Market Key Performance Indicators |
8.1 Average age of diagnosis of type 1 diabetes in Israel |
8.2 Percentage of population with access to diabetes education programs |
8.3 Adoption rate of innovative diabetes management technologies |
8.4 Number of research studies and clinical trials focused on type 1 diabetes in Israel |
9 Israel Type 1 Diabetes Market - Opportunity Assessment |
9.1 Israel Type 1 Diabetes Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Type 1 Diabetes Market Opportunity Assessment, By Treatment Approach, 2021 & 2031F |
9.3 Israel Type 1 Diabetes Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Israel Type 1 Diabetes Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 Israel Type 1 Diabetes Market - Competitive Landscape |
10.1 Israel Type 1 Diabetes Market Revenue Share, By Companies, 2024 |
10.2 Israel Type 1 Diabetes Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here